Curis
CRIS
#11076
Rank
C$5.82 M
Marketcap
C$0.61
Share price
-9.03%
Change (1 day)
-61.55%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$20.42

According to Curis's latest financial reports the company's current EPS (TTM) is C-$20.39. In 2025 the company made an earnings per share (EPS) of C-$34.14 an increase over its 2024 EPS that were of C-$201.62.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$20.42-40.18%
2025C-$34.14-83.07%
2024C-$201.62-22.15%
2023C-$258.98-26.17%
2022C-$350.7622.3%
2021C-$286.80-25.37%
2020C-$384.31-30.93%
2019C-$556.39-2.02%
2018C-$567.86
2016C-$1,291-10%
2015C-$1,434138.1%
2014C-$602.2840%
2013C-$430.20-25%
2012C-$573.6066.67%
2011C-$344.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.02-104.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.48-131.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.52-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.96-124.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.24-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$4.56-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$7.23-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA